Neostem Inc (NYSEMKT:NBS)

CAPS Rating: 4 out of 5

Recs

0
Player Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:14:51 PM : Outperform Start Price: $0.57 NBS Score: -18.14

Stem cell expertise.

Featured Broker Partners


Advertisement